Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Solid Tumours × brigimadlin × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Biliary Tract Neoplasms 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Tertiary Lymphoid Structures 1 Solid Tumours 1 Sarcoma 1 Pancreatic Neoplasms 1 Lung Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06619509 2026-04-14

A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This Medicine

Boehringer Ingelheim

Phase 2 Active not recruiting

Other solid neoplasm

Solid Tumours

Data powered by HemOnc (CC BY 4.0) Colophon ⚡